The University of Nevada, Reno School of Medicine

Project Society: Charting the Course to Higher Targets With JAK Inhibition in Atopic Dermatitis: Insights for Community HCPs

Explore how Janus kinase (JAK) inhibitors and higher treatment targets are shaping conversations in moderate-to-severe atopic dermatitis (AD) care.

Discuss the latest safety and efficacy data for JAK inhibitors to inform evolving treatment choices in moderate-to-severe AD.